Stryker Recalls their Trident Acetabular Cups
On May 5, 2008, the FDA issued its third warning letter to implant manufacturer Stryker Corporation regarding serious
issues with its implanted prosthetic devices. The warning discusses issues regarding the division’s handling of clinical
studies, its quality system, medical device reporting procedures, and falsification of documentation approving implantation.
Click Here for the full bulletin
Failure and Defect of the Zimmer Durom Hip Replacement System
We are aggressively investigating and reviewing cases where patients have experienced defects and failures involving the
Durom hip replacement cups manufactured by multinational joint replacement device manufacturer Zimmer, Inc.
It is believed that Zimmer marketed the Durom hip replacement cup knowing that this hip cup was defectively
designed and would result in a significant failure rate.
Click Here for the full bulletin
Smith and Nephew Oxinium Knee Implants Recall
We are currently handling cases involving the Smith and Nephew Oxinium knee implants, including the recalled "cementless"
version of the Profix II and Genesis II models. These defective devices were implanted up until the date of the recall,
September of 2003. The manufacturer issued a voluntary recall based upon a high number of failures on the implanted knees.
Click Here for the full bulletin
DigiTek Digoxin Recall
On April 28, 2008, a Digitek (digoxin tablets) recall was announced for the heart medication sold throughout the United States
under the “Bertek” and “UDL” labels. Experienced attorneys at the law firm of Houssiere, Durant &
Houssiere, LLP are actively reviewing potential Digitek (digoxin tablets) lawsuits throughout the United States.
Individuals who have suffered a stroke or death as a result of digitalis toxicity may be entitled to financial compensation.
Digitek (digoxin tablets) was recalled because the tablets may be twice as thick, and contain double the dose of medication
than it should. The stronger tablets may cause toxicity in renal-failure patients, stroke and/or death. On May 9, 2008 the
Wall Street Journal published an article discussing the dangers of the Digitek (digoxin tablets) which can be viewed by
clicking here.
Click Here for the full bulletin
Medtronic implantable defibrillator defect
Medtronic, the nation's largest manufacturer of heart implant devices has stopped selling its implantable Medtronic
defibrillator because of a defect that causes a risk of electrical shock and potential death. This defect was first reported
in the New York Times on October 15, 2007,
after reports of at least five patient deaths associated with the defibrillator leads.
Click Here for the full bulletin
Important Drug Warning : REGRANEX
Doctors were recently sent a letter by the manufacturer Ortho-McNeil informing them that the ointment REGRANEX (Becaplermin)
given for treatment of diabetic ulcers have been found to cause significant increase in Cancer when 3 or more tubes
are given. Please call your doctors immediately if you are using REGRANEX. You can
contact us if you want to discuss your legal options.
Antibiotic and Chemotherapy Ports Break
There have been numerous reports to the FDA of problems with vascular access ports manufactured by Horizon Medical Products where
the plastic catheters are breaking off and traveling to other sites in the body like the heart or pulmonary artery and becoming
stuck there.
Click Here for the full bulletin
 Updated Bulletins July 2008
The following bulletins have been added or updated recently! Check them out.
Click here for the Bulletins index page.
|
